Cardiovascular Risk in Survivors of Cancer

Zheng, Henry; Onderko, Laura; Francis, Sanjeev

doi:10.1007/s11886-017-0873-7

Cited by 15 publications

(9 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While advances in cancer screening and treatment have led to vast improvements in survival, cancer survivors now face an increased risk of cancer recurrence and second primary cancers [2]. Additionally, cancer survivors experience many other late and long-term effects of cancer and its treatment including increased risk for cardiovascular disease, [3,4] chronic health conditions, [5] and psychological effects [6].…”

Section: Introductionmentioning

confidence: 99%

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors

et al. 2019

View full text Add to dashboard Cite

Purpose: Our study aims to determine whether receipt of a written survivorship care plan (SCP) is associated with five self-reported health behaviors known to be correlated with positive longterm outcomes for cancer survivors: 1) attending a recent medical appointment, 2) exercise in the past month, 3) non-smoking status, 4) mammography in the past two years, and 5) up-to-date colorectal cancer screening. Methods: In this secondary data analysis, we used data from the 2014 Behavioral Risk Factor Surveillance System (BRFSS) cancer survivorship module for 1,855 off-treatment cancer survivors. Multivariable logistic regression accounting for complex survey design was used to examine the association between SCP receipt and each of the five preventive health behaviors. Results: Overall, 37% (669/1,855) of survivors reported receiving a written survivorship care plan. In the logistic regression models adjusted for sociodemographic and disease-related factors, SCP receipt was associated with having a recent medical appointment (OR (95% CI): 2.81 (1.27-6.22)), exercise in the past month (1.78 (1.20-2.63)), non-smoking status (2.27 (1.26-4.12)), and

show abstract

Section: Introductionmentioning

confidence: 99%

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors

et al. 2019

View full text Add to dashboard Cite

show abstract

“…However, newer protocols limit the chemotherapy dosing and improve radiation accuracy, which has shown to decrease the acute clinically evident cardiovascular complications to less than 1% [ 122 ]. A greater risk has been registered in children who were facing pre-existing cardiovascular risk factors, hence the importance of early recognition of heart disease in cancer survivors [ 123 ]. It is estimated that as many one in eight CCS treated with anthracyclines and chest radiotherapy will experience a life-threatening cardiovascular event 30 years after the treatment of childhood cancer [ 124 ].…”

Section: Cardiotoxicity and Cardiomyopathymentioning

confidence: 99%

Cardiovascular Risk in Childhood Cancer Survivors

2022

View full text Add to dashboard Cite

Cancer is a prominent cause of death worldwide in the pediatric population. Since childhood cancer is not possible to prevent, it is essential to focus on a prompt and correct diagnosis followed by effective, evidence-based therapy with individualized supportive care. Given the enhancement of childhood cancer management over the past decades, survival rate has significantly improved, thus leading to the progression of several late effects, including metabolic derangements. These metabolic imbalances are associated with the underlying disease and the cancer treatments. As a result, the metabolic state may contribute to a high risk of cardiovascular morbidity and premature mortality among childhood cancer survivors. This review aims to summarize the potential pathophysiological mechanisms linked to the risk of diabetes and metabolic syndrome and screening recommendations. Further investigations are needed to clarify the underlying mechanisms of such metabolic abnormalities and to improve long-term cardiometabolic survival among these patients.

show abstract

“…Chemotherapy -anthracyclines, trastuzumab, cyclophosphamide, 5-fluorouracil, angiogenesis drugs, thyroid kinases, etc. increase the risk of cardiovascular diseases, having a direct toxic effect on the myocardium [5,6].…”

Section: Introductionmentioning

confidence: 99%

Chemotherapy and chemoembolization of patients with oncopathology as a risk factor for the development of myocardial dysfunction

et al. 2023

View full text Add to dashboard Cite

Considering the aging of the population, the combination of cardiovascular diseases with oncopathology is gaining more relevance. Liver cancer occupies the 6th place in the structure of the incidence of neoplasms and the 3rd place in mortality from all oncological diseases. One of the main methods of treating patients with liver cancer is chemotherapy and chemoembolization, which significantly affect the myocardium, developing cardiotoxicity. Myocardial damage is reflected in the development of heart failure, which subsequently is the main cause of death in cancer patients.

show abstract

Cardiovascular Risk in Survivors of Cancer

Cited by 15 publications

References 45 publications

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors

Cardiovascular Risk in Childhood Cancer Survivors

Chemotherapy and chemoembolization of patients with oncopathology as a risk factor for the development of myocardial dysfunction

Contact Info

Product

Resources

About